These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 14734567

  • 1. Threonine 98, the pivotal residue of tissue inhibitor of metalloproteinases (TIMP)-1 in metalloproteinase recognition.
    Lee MH, Rapti M, Knaüper V, Murphy G.
    J Biol Chem; 2004 Apr 23; 279(17):17562-9. PubMed ID: 14734567
    [Abstract] [Full Text] [Related]

  • 2. Delineating the molecular basis of the inactivity of tissue inhibitor of metalloproteinase-2 against tumor necrosis factor-alpha-converting enzyme.
    Lee MH, Rapti M, Murphy G.
    J Biol Chem; 2004 Oct 22; 279(43):45121-9. PubMed ID: 15308656
    [Abstract] [Full Text] [Related]

  • 3. Unveiling the surface epitopes that render tissue inhibitor of metalloproteinase-1 inactive against membrane type 1-matrix metalloproteinase.
    Lee MH, Rapti M, Murphy G.
    J Biol Chem; 2003 Oct 10; 278(41):40224-30. PubMed ID: 12869573
    [Abstract] [Full Text] [Related]

  • 4. Protein engineering of the tissue inhibitor of metalloproteinase 1 (TIMP-1) inhibitory domain. In search of selective matrix metalloproteinase inhibitors.
    Wei S, Chen Y, Chung L, Nagase H, Brew K.
    J Biol Chem; 2003 Mar 14; 278(11):9831-4. PubMed ID: 12515831
    [Abstract] [Full Text] [Related]

  • 5. Constraining specificity in the N-domain of tissue inhibitor of metalloproteinases-1; gelatinase-selective inhibitors.
    Hamze AB, Wei S, Bahudhanapati H, Kota S, Acharya KR, Brew K.
    Protein Sci; 2007 Sep 14; 16(9):1905-13. PubMed ID: 17660250
    [Abstract] [Full Text] [Related]

  • 6. Residue 2 of TIMP-1 is a major determinant of affinity and specificity for matrix metalloproteinases but effects of substitutions do not correlate with those of the corresponding P1' residue of substrate.
    Meng Q, Malinovskii V, Huang W, Hu Y, Chung L, Nagase H, Bode W, Maskos K, Brew K.
    J Biol Chem; 1999 Apr 09; 274(15):10184-9. PubMed ID: 10187802
    [Abstract] [Full Text] [Related]

  • 7. Total conversion of tissue inhibitor of metalloproteinase (TIMP) for specific metalloproteinase targeting: fine-tuning TIMP-4 for optimal inhibition of tumor necrosis factor-{alpha}-converting enzyme.
    Lee MH, Rapti M, Murphy G.
    J Biol Chem; 2005 Apr 22; 280(16):15967-75. PubMed ID: 15713681
    [Abstract] [Full Text] [Related]

  • 8. E. coli expression of TIMP-4 and comparative kinetic studies with TIMP-1 and TIMP-2: insights into the interactions of TIMPs and matrix metalloproteinase 2 (gelatinase A).
    Troeberg L, Tanaka M, Wait R, Shi YE, Brew K, Nagase H.
    Biochemistry; 2002 Dec 17; 41(50):15025-35. PubMed ID: 12475252
    [Abstract] [Full Text] [Related]

  • 9. Matrix metalloproteinase-10 (MMP-10) interaction with tissue inhibitors of metalloproteinases TIMP-1 and TIMP-2: binding studies and crystal structure.
    Batra J, Robinson J, Soares AS, Fields AP, Radisky DC, Radisky ES.
    J Biol Chem; 2012 May 04; 287(19):15935-46. PubMed ID: 22427646
    [Abstract] [Full Text] [Related]

  • 10. Directed evolution of the metalloproteinase inhibitor TIMP-1 reveals that its N- and C-terminal domains cooperate in matrix metalloproteinase recognition.
    Raeeszadeh-Sarmazdeh M, Greene KA, Sankaran B, Downey GP, Radisky DC, Radisky ES.
    J Biol Chem; 2019 Jun 14; 294(24):9476-9488. PubMed ID: 31040180
    [Abstract] [Full Text] [Related]

  • 11. Reactive site mutations in tissue inhibitor of metalloproteinase-3 disrupt inhibition of matrix metalloproteinases but not tumor necrosis factor-alpha-converting enzyme.
    Wei S, Kashiwagi M, Kota S, Xie Z, Nagase H, Brew K.
    J Biol Chem; 2005 Sep 23; 280(38):32877-82. PubMed ID: 16079149
    [Abstract] [Full Text] [Related]

  • 12. Matrix metalloproteinase expression and activity following prostaglandin F(2 alpha)-induced luteolysis.
    Ricke WA, Smith GW, Smith MF.
    Biol Reprod; 2002 Mar 23; 66(3):685-91. PubMed ID: 11870075
    [Abstract] [Full Text] [Related]

  • 13. Thermodynamic Basis of Selectivity in the Interactions of Tissue Inhibitors of Metalloproteinases N-domains with Matrix Metalloproteinases-1, -3, and -14.
    Zou H, Wu Y, Brew K.
    J Biol Chem; 2016 May 20; 291(21):11348-58. PubMed ID: 27033700
    [Abstract] [Full Text] [Related]

  • 14. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
    Bigg HF, Morrison CJ, Butler GS, Bogoyevitch MA, Wang Z, Soloway PD, Overall CM.
    Cancer Res; 2001 May 01; 61(9):3610-8. PubMed ID: 11325829
    [Abstract] [Full Text] [Related]

  • 15. Crystal structure of the catalytic domain of matrix metalloproteinase-1 in complex with the inhibitory domain of tissue inhibitor of metalloproteinase-1.
    Iyer S, Wei S, Brew K, Acharya KR.
    J Biol Chem; 2007 Jan 05; 282(1):364-71. PubMed ID: 17050530
    [Abstract] [Full Text] [Related]

  • 16. The activity of a designer tissue inhibitor of metalloproteinases (TIMP)-1 against native membrane type 1 matrix metalloproteinase (MT1-MMP) in a cell-based environment.
    Lee MH, Atkinson S, Rapti M, Handsley M, Curry V, Edwards D, Murphy G.
    Cancer Lett; 2010 Apr 01; 290(1):114-22. PubMed ID: 19815335
    [Abstract] [Full Text] [Related]

  • 17. Dynamic changes in the expression of matrix metalloproteinases and their inhibitors, TIMPs, during hepatic fibrosis induced by alcohol in rats.
    Xu GF, Li PT, Wang XY, Jia X, Tian DL, Jiang LD, Yang JX.
    World J Gastroenterol; 2004 Dec 15; 10(24):3621-7. PubMed ID: 15534918
    [Abstract] [Full Text] [Related]

  • 18. Metalloproteinase and inhibitor expression profiling of resorbing cartilage reveals pro-collagenase activation as a critical step for collagenolysis.
    Milner JM, Rowan AD, Cawston TE, Young DA.
    Arthritis Res Ther; 2006 Dec 15; 8(5):R142. PubMed ID: 16919164
    [Abstract] [Full Text] [Related]

  • 19. Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat.
    Peterson JT, Li H, Dillon L, Bryant JW.
    Cardiovasc Res; 2000 May 15; 46(2):307-15. PubMed ID: 10773235
    [Abstract] [Full Text] [Related]

  • 20. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis.
    Kossakowska AE, Edwards DR, Lee SS, Urbanski LS, Stabbler AL, Zhang CL, Phillips BW, Zhang Y, Urbanski SJ.
    Am J Pathol; 1998 Dec 15; 153(6):1895-902. PubMed ID: 9846979
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.